Welcome to the CEO Roundtable on Cancer

Reps from CEORT Members, HBCUs meet about Going for Gold

Representatives from seven Historically Black Colleges and Universities met on April 5-6 with CEO Roundtable on Cancer staff and partners SAS Analytics, Amgen, Merck, and Jasper Health to identify opportunities and areas of collaboration for our Going for Gold initiative to expand access to cancer detection, prevention, and treatment and to improve health in underserved communities.

Learn more
New leaders join CEORT team

Project Data Sphere® President Bill Louv, PhD, is stepping up to lead the CEO Roundtable on Cancer as our Chief Executive Officer effective immediately. We're also excited to announce two new directors for our organization: David M. Reese, MD, Executive Vice President of R&D at Amgen, and Major General Elder Granger, MD, President and CEO of THE 5Ps, LLC.

Learn more
Scientific Publications reflect progress by MCC Registry Program

The Merkel Cell Carcinoma (MCC) Patient Registry initiative organized by Project Data Sphere is off to a fast start in 2022 with four manuscripts accepted for publication and a key contributor to the program, Dr. David Miller from Mass General Brigham and his team, has submitted two new manuscripts. Miller is co-chair of PDS' Merkel Cell Carcinoma Task Force.

Learn more
FDA Grand Rounds Features Images and Algorithms Program

Project Data Sphere’s Images & Algorithms (I&A) Program presented preliminary results from its autoRECIST project at the FDA Research Grand Rounds on Feb. 25. Nearly 200 attendees participated in this webinar which generated a great discussion. The goal of the autoRECIST project is to develop deep-learning algorithms to reduce the time and cost and improve the performance of imaging in clinical trials, shortening the time from discovery to implementation, improving the accuracy of the reviews, and, ultimately, improving patient lives

Learn more

Our Mission

The mission of the CEO Roundtable on Cancer is to make continual progress toward the elimination of cancer as a personal disease and public health problem through initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to treatment, and hasten the discovery of effective therapies.

Workplace Wellness

A workplace wellness accreditation program designed to encourage healthy behaviors and improve health outcomes for employees by promoting prevention measures, encouraging early detection through cancer screenings, and ensuring access to quality care.

Research Innovation

Life sciences initiatives that bring together oncology, biotechnology and pharmaceutical companies to collaborate on removing obstacles and finding new ways to accelerate discovery and development of new therapies for cancer patients.

Global Cancer Control

Programs that catalyze progress in employee health at a global level and provide an environment that enables the compilation of historical oncology clinical trial data that will open new avenues of research.

Data Platform continuously improving

Researchers who have not logged on to the Project Data Sphere data platform recently are invited to check out all the improvements we’ve been making to respond to user feedback. Data accessed via the platform has contributed to at least 138 peer-reviewed publications and 15 associated with research programs.

Learn more

July is Minority Mental Health Awareness Month

Mental and Emotional health is an important component of the CEO Cancer Gold Standard Framework. We are joining @MinorityHealth and others in addressing negative perceptions and stigma surrounding mental health.

Learn more about how your organization can become CEO Cancer Gold Standard accredited at https://CancerGoldStandard.org

Learn how we can start the conversation about managing mental health: https://minorityhealth.hhs.gov/minority-mental-health

Learn More